BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10987442)

  • 1. Design and synthesis of triglyceride analogue biotinylated suicide inhibitors for directed molecular evolution of lipolytic enzymes.
    Deussen HJ; Danielsen S; Breinholt J; Borchert TV
    Bioorg Med Chem Lett; 2000 Sep; 10(17):2027-31. PubMed ID: 10987442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biotinylated suicide inhibitor for directed molecular evolution of lipolytic enzymes.
    Deussen HJ; Danielsen S; Breinholt J; Borchert TV
    Bioorg Med Chem; 2000 Mar; 8(3):507-13. PubMed ID: 10732966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterically hindered triacylglycerol analogues as potent inhibitors of human digestive lipases.
    Constantinou-Kokotou V; Magrioti V; Verger R
    Chemistry; 2004 Mar; 10(5):1133-40. PubMed ID: 15007804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2-Oxo amide triacylglycerol analogues and study of their inhibition effect on pancreatic and gastric lipases.
    Kokotos G; Verger R; Chiou A
    Chemistry; 2000 Nov; 6(22):4211-7. PubMed ID: 11128286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of alpha-keto triglyceride analogues as inhibitors for Staphylococcus hyicus lipase.
    Simons JW; Cox RC; Egmond MR; Verheij HM
    Biochemistry; 1999 May; 38(19):6346-51. PubMed ID: 10320365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphonate analogues of triacylglycerols are potent inhibitors of lipase.
    Mannesse ML; Boots JW; Dijkman R; Slotboom AJ; van der Hijden HT; Egmond MR; Verheij HM; de Haas GH
    Biochim Biophys Acta; 1995 Oct; 1259(1):56-64. PubMed ID: 7492616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors.
    Jin J; Huang S; Wang L; Leng Y; Lu W
    Chem Biol Drug Des; 2017 Dec; 90(6):1122-1133. PubMed ID: 28548386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of new bis-1,3,4,2-triazaphospholinoalkane derivatives as in vitro α-amylase and lipase inhibitors.
    Hamzaoui S; Ben Salah B; Hamden K; Rekik A; Kossentini M
    Arch Pharm (Weinheim); 2015 Mar; 348(3):188-93. PubMed ID: 25676018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of cutinase covalently inhibited by a triglyceride analogue.
    Longhi S; Mannesse M; Verheij HM; De Haas GH; Egmond M; Knoops-Mouthuy E; Cambillau C
    Protein Sci; 1997 Feb; 6(2):275-86. PubMed ID: 9041628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-based proteomics of lipolytic enzymes.
    Birner-Gruenberger R; Hermetter A
    Curr Drug Discov Technol; 2007 Jun; 4(1):1-11. PubMed ID: 17630923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A versatile library of activity-based probes for fluorescence detection and/or affinity isolation of lipolytic enzymes.
    Susani-Etzerodt H; Schmidinger H; Riesenhuber G; Birner-Gruenberger R; Hermetter A
    Chem Phys Lipids; 2006 Oct; 144(1):60-8. PubMed ID: 16949065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of biotinylated photoaffinity probes based on arylsulfonamide gamma-secretase inhibitors.
    Fuwa H; Hiromoto K; Takahashi Y; Yokoshima S; Kan T; Fukuyama T; Iwatsubo T; Tomita T; Natsugari H
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4184-9. PubMed ID: 16766183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic and Natural Lipase Inhibitors.
    Bialecka-Florjanczyk E; Fabiszewska AU; Krzyczkowska J; Kurylowicz A
    Mini Rev Med Chem; 2018; 18(8):672-683. PubMed ID: 27484624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL).
    Mayer N; Schweiger M; Melcher MC; Fledelius C; Zechner R; Zimmermann R; Breinbauer R
    Bioorg Med Chem; 2015 Jun; 23(12):2904-16. PubMed ID: 25778769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Atglistatin closely related analogues: Synthesis and structure-activity relationship towards adipose triglyceride lipase inhibition.
    Roy PP; D'Souza K; Cuperlovic-Culf M; Kienesberger PC; Touaibia M
    Eur J Med Chem; 2016 Aug; 118():290-8. PubMed ID: 27155760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipase and phospholipase inhibitors: design and applications.
    Venable ME
    Methods Mol Biol; 2012; 861():139-48. PubMed ID: 22426717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors.
    S N C S; Bhurta D; Kantiwal D; George G; Monga V; Paul AT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3749-3754. PubMed ID: 28705641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme inhibitors as chemical tools to study enzyme catalysis: rational design, synthesis, and applications.
    Hiratake J
    Chem Rec; 2005; 5(4):209-28. PubMed ID: 16041744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay.
    Hou W; Fang J; Su L; Ye H; Ruan BH
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2498-2502. PubMed ID: 31324513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.